Cellyan Biotechnology (HKPD) director reports 18,468 Class A shares on Form 3

Rhea-AI Filing Summary

Cellyan Biotechnology Co., Ltd director Wong Lap Sun has filed an initial Form 3 reporting beneficial ownership in the company. The filing shows direct ownership of 18,468 Class A Ordinary Shares as of the reported date, without any associated buy or sell transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wong Lap Sun

Role null

Type	Security	Shares	Price	Value
holding	Class A Ordinary Shares	--	--	--

Holdings After Transaction: Class A Ordinary Shares — 18,468 shares (Direct, null)

Footnotes (1)

Key Figures

Shares owned: 18,468 shares Form type: Form 3 Ownership type: Direct (code D)

3 metrics

Shares owned 18,468 shares Class A Ordinary Shares directly owned following reported position

Form type Form 3 Initial statement of beneficial ownership by director

Ownership type Direct (code D) Classification of 18,468 Class A Ordinary Shares

Key Terms

Form 3, Class A Ordinary Shares, beneficial ownership, direct ownership

4 terms

Form 3 regulatory

"Director Wong Lap Sun has filed an initial Form 3 reporting beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Class A Ordinary Shares financial

"The filing shows direct ownership of 18,468 Class A Ordinary Shares"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

beneficial ownership financial

"an initial Form 3 reporting beneficial ownership in the company"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

direct ownership financial

"The Form 3 classifies the holdings as direct ownership"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/10/2026 - 03:11 PM Accepted by SEC EDGAR 06/10/2026 - 03:10 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wong Lap Sun

(Last) (First) (Middle)

ROOM B1, 5/F, WELL TOWN INDUSTRIAL

BUILDING, 13 KO FAI ROAD

(Street)

YAU TONG KOWLOON 00000

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellyan Biotechnology Co., Ltd [ HKPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	18,468	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Lap Sun Wong	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Cellyan Biotechnology (HKPD) disclose in this Form 3?

Cellyan Biotechnology discloses initial insider holdings for director Wong Lap Sun on Form 3. The filing reports 18,468 Class A Ordinary Shares held directly, establishing the baseline ownership position without indicating any recent purchase or sale transactions.

How many Cellyan Biotechnology (HKPD) shares does Wong Lap Sun hold?

The Form 3 reports that director Wong Lap Sun directly owns 18,468 Class A Ordinary Shares of Cellyan Biotechnology. This figure represents the total shares beneficially owned following the reported position and serves as a starting point for future insider transaction reporting.

Does the Cellyan Biotechnology (HKPD) Form 3 show any insider buying or selling?

The Form 3 does not show insider buying or selling activity. Instead, it records a holding entry for 18,468 Class A Ordinary Shares owned directly by director Wong Lap Sun, establishing his current beneficial ownership without reporting new transactions.

What type of security is reported in Cellyan Biotechnology (HKPD) Form 3?

The filing reports holdings of Class A Ordinary Shares of Cellyan Biotechnology. Director Wong Lap Sun is shown as directly owning 18,468 of these shares, and no derivative securities or option positions are listed in the provided Form 3 data.

Is the ownership reported by Wong Lap Sun in HKPD direct or indirect?

The Form 3 classifies the holdings as direct ownership. For the reported position of 18,468 Class A Ordinary Shares, the ownership code is "D," indicating the shares are held directly rather than through an intermediary entity or indirect structure.